Abrupt Regression of a Meningioma after Discontinuation of Cyproterone Treatment

References

1. 1.↵
   1. Froelich S,
   2. Dali-Youcef N,
   3. Boyer P,
   4. et al

   . Does cyproterone acetate promote multiple meningiomas? In: Proceedings of the 10th European Congress of Endocrinology, Berlin, Germany. May 3–7, 2008

   Google Scholar
2. 2.↵
   1. Wigertz A,
   2. Lonn S,
   3. Hall P,
   4. et al

   . Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 2008;17:2663–70

   Abstract/FREE Full TextGoogle Scholar
3. 3.↵
   1. Smith JS,
   2. Quinones-Hinojosa A,
   3. Harmon-Smith M,
   4. et al

   . Sex steroid and growth factor profile of a meningioma associated with pregnancy. Can J Neurol Sci 2005;32:122–27

   PubMedGoogle Scholar
4. 4.↵
   1. Blankenstein MA,
   2. Verheijen FM,
   3. Jacobs JM,
   4. et al

   . Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 2000;65:795–800

   Google Scholar
5. 5.↵
   1. Hatiboglu MA,
   2. Cosar M,
   3. Iplikcioglu AC,
   4. et al

   . Sex steroid and epidermal growth factor profile of giant meningiomas associated with pregnancy. Surg Neurol 2008;69:356–62

   CrossRefPubMedGoogle Scholar
6. 6.↵
   1. Moss J,
   2. DeCastro R,
   3. Patronas NJ,
   4. et al

   . Meningiomas in lymphangioleiomyomatosis. JAMA 2001;286:1879–81

   CrossRefPubMedWeb of ScienceGoogle Scholar
7. 7.↵
   1. Wigertz A,
   2. Lonn S,
   3. Mathiesen T,
   4. et al

   . Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 2006;164:629–36

   Abstract/FREE Full TextGoogle Scholar
8. 8.↵
   1. Gazzeri R,
   2. Galarza M,
   3. Gazzeri G

   . Growth of a meningioma in a transsexual patient after estrogen-progestin therapy. N Engl J Med 2007;357:2411–12

   CrossRefPubMedGoogle Scholar
9. 9.↵
   1. Matsuda Y,
   2. Kawamoto K,
   3. Kiya K,
   4. et al

   . Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo. J Neurosurg 1994;80:527–34

   PubMedWeb of ScienceGoogle Scholar
10. 10.↵
    1. de Almeida JP,
    2. Petteys RJ,
    3. Sciubba DM,
    4. et al

    . Regression of intracranial meningioma following intratumoral hemorrhage. J Clin Neurosci 2009;16:1246–49

    CrossRefPubMedGoogle Scholar
11. 11.↵
    1. Pozzati E,
    2. Zucchelli M,
    3. Schiavina M,
    4. et al

    . Rapid growth and regression of intracranial meningiomas in lymphangioleiomyomatosis: case report. Surg Neurol 2007;68:671–74

    CrossRefPubMedGoogle Scholar
12. 12.↵
    1. Shimizu J,
    2. Matsumoto M,
    3. Yamazaki E,
    4. et al

    . Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration. Neurol Med Chir (Tokyo) 2008;48:227–30

    CrossRefPubMedGoogle Scholar
13. 13.↵
    1. Jay JR,
    2. MacLaughlin DT,
    3. Riley KR,
    4. et al

    . Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 1985;62:757–62

    PubMedWeb of ScienceGoogle Scholar